ArticleThe Korean journal of helicobacter and upper gastrointestinal research2026
Risk Factors and Prophylaxis for Post-Procedural Stricture After Esophageal Endoscopic Submucosal Dissection.
Article in The Korean journal of helicobacter and upper gastrointestinal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic submucosal dissection (ESD) is the standard treatment for superficial esophageal neoplasms; however, post-procedural stricture remains a significant challenge. The risk factors and prophylaxis for post-procedural stricture in 128 lesions treated with esophageal ESD over 12 years, were analyzed. There was a stricture in 13 lesions (10.2%), with rates of 2.0%, 1.9%, and 44.0% for lesions with a <50%, 50% to 75%, and >75% circumferential extent of the post-ESD mucosal defect, respectively (p<0.001). Prophylactic treatments included no prophylaxis (40.6%), local triamcinolone injection (42.2%), and combined triamcinolone injection plus oral prednisolone (17.2%). In univariate analysis, older age, larger tumor and specimen size, higher Japan Esophageal Society classification, longer procedure time, and a >75% extent of circumferential mucosal defect, were associated with stricture. In multivariate analysis adjusted for age, a >75% extent of circumferential mucosal defect remained independently associated with stricture (adjusted odds ratio, 34.773; 95% confidence interval, 6.880-175.747; p<0.001). The circumferential extent of the post-ESD mucosal defect was the strongest risk factor for post-ESD stricture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.